Found 4370 articles for: ""
Intralesional Bleomycin for Warts: A Review
June 2006 | Volume 5 | Issue 6 | Original Article | 499 | Copyright © June 2006
Intralesional bleomycin has been used for the treatment of warts since the 1970s. Currently, there is a limited amount of evidence from randomized placebo-controlled trials comparing intralesional bl...
Read MoreHow Clarence S. Livingood and His Manual of Dermatology Influenced Dermatologic Therapy
June 2006 | Volume 5 | Issue 6 | Original Article | 497 | Copyright © June 2006
Clarence S. Livingood and his mentors, Pillsbury and Sulzberger, wrote the Manual of Dermatology, a book that was the dermatologic handbook of choice for thousands of medical officers in World War II...
Read MoreClinical Trial Review
February 2006 | Volume 5 | Issue 2 | Features | 204 | Copyright © February 2006
Schools of Pharmacology
February 2006 | Volume 5 | Issue 2 | Features | 201 | Copyright © February 2006
Pipeline Previews
February 2006 | Volume 5 | Issue 2 | Features | 199 | Copyright © February 2006
Washington Whispers
February 2006 | Volume 5 | Issue 2 | Features | 196 | Copyright © February 2006
Indoor Tanning—Magnitude of the Health Issue
February 2006 | Volume 5 | Issue 2 | Case Reports | 193 | Copyright © February 2006
Poikilodermatous Variant of Mycosis Fungoides
February 2006 | Volume 5 | Issue 2 | Case Reports | 190 | Copyright © February 2006
Mycosis Fungoides (MF) is a T-cell lymphoma initially presenting in the skin. Many clinical variants exist including follicular, vesicular, poikilodermic, hypo- and hyperpigmented, ichthyosiform and ...
Read MoreParaffinomas of the Facial Area: Treatment with Systemic and Intralesional Steroids
February 2006 | Volume 5 | Issue 2 | Case Reports | 186 | Copyright © February 2006
We present a case of a 32-year-old male patient with a history HIV infection, who administered vitamin E and almond oil into the malar region and chin. On histology the main pathological finding was ...
Read MoreThe Incidence of Recurrent Herpes Simplex and Herpes Zoster Infection during Treatment with Arsenic Trioxide
February 2006 | Volume 5 | Issue 2 | Case Reports | 182 | Copyright © February 2006
We report the incidence of varicella zoster virus (VZV) and herpes simplex virus (HSV) infection in patients with multiple myeloma and colon cancer who were treated with arsenic trioxide for their di...
Read MoreRapid Growth of Merkel Cell Carcinoma after Treatment with Rituximab
February 2006 | Volume 5 | Issue 2 | Case Reports | 180 | Copyright © February 2006
Merkel cell carcinoma is an uncommon neuroendocrine carcinoma of the skin. We report a case of rapid growth of Merkel cell carcinoma after treatment with rituximab, a new anti-CD20 monoclonal antibod...
Read MoreInfliximab Associated New-Onset Psoriasis
February 2006 | Volume 5 | Issue 2 | Case Reports | 178 | Copyright © February 2006
Infliximab infusion is not yet FDA-approved for psoriasis but has been reported to be very effective for plaque psoriasis. We report 2 patients without a history of psoriasis who after administration...
Read MoreAn Unusual Presentation of Refractory Cutaneous Langerhans Cell Histiocytosis in an Adult
February 2006 | Volume 5 | Issue 2 | Case Reports | 174 | Copyright © February 2006
Primary cutaneous adult-onset Langerhans cell histiocytosis is a rare disorder typically characterized by a diffuse papular rash accentuated in a seborrheic distribution. We present a unique case of ...
Read MoreMechanisms of Action of New Treatment Modalities for Actinic Keratosis
February 2006 | Volume 5 | Issue 2 | Original Article | 167 | Copyright © February 2006
Actinic keratosis (AK) constitutes the initial lesion in a disease continuum that can progress to invasive squamous cell carcinoma (SCC). In this article, we describe the mechanisms of action, tolera...
Read MoreThe Clinical Impact of Vehicle Technology Using a Patented Formulation of Benzoyl Peroxide 5%/Clindamycin 1% Gel Containing Dimethicone and Glycerin in Combination with Topical Retinoids and Sunscreens
February 2006 | Volume 5 | Issue 2 | Original Article | 160 | Copyright © February 2006
A major challenge encountered in clinical practice in patients with acne vulgaris is irritation related to topical medications used for treatment. Advances in vehicle technology have improved formula...
Read MoreBilateral Comparison of the Efficacy and Tolerability of 3% Diclofenac Sodium Gel and 5% 5-Fluorouracil Cream in the Treatment of Actinic Keratoses of the Face and Scalp
February 2006 | Volume 5 | Issue 2 | Original Article | 156 | Copyright © February 2006
Actinic keratoses (AKs) are a common precancerous condition and are said to account for 14% of visits to dermatologists in the US each year. Along with cryotherapy, topical treatments are a mainstay ...
Read MoreThe Use of Photodynamic Therapy in Dermatology: Results of a Consensus Conference
February 2006 | Volume 5 | Issue 2 | Original Article | 140 | Copyright © February 2006
Photodynamic therapy (PDT) has significant promise in improving outcomes of patients with a variety of cutaneous conditions. A group of experts met to review the principles, indications, and clinical...
Read MoreOne-Week Treatment with 0.5% Fluorouracil Cream Prior to Cryosurgery in Patients with Actinic Keratoses: A Double-Blind, Vehicle-Controlled, Long-Term Study
February 2006 | Volume 5 | Issue 2 | Original Article | 133 | Copyright © February 2006
Topical fluorouracil is currently approved for the treatment of actinic keratosis (AK) and is often used prior to or following cryosurgery as interval therapy in patients with severe AK lesions. No r...
Read MoreThe Position not the Presence of the Halogen in Corticosteroids Influences Potency and Side Effect
February 2006 | Volume 5 | Issue 2 | Original Article | 125 | Copyright © February 2006
Many topical corticosteroids currently on the market contain a halogen substitution at the C6, C9, or the side-chain C21 position of the corticosteroid skeleton. These modifications have enhanced the...
Read MorePart 1 of a 2 Part Article: A Comprehensive Review of Imatinib Mesylate (Gleevec) for Dermatological Diseases
February 2006 | Volume 5 | Issue 2 | Original Article | 117 | Copyright © February 2006
Imatinib mesylate (Gleevec, also known as STI-571), is an approved oral treatment for patients with chronic myeloid leukemia (CML). It blocks the activity of Abelson cytoplasmic tyrosine kinase (ABL)...
Read More